More data on potential for drug interactions with zolpidem and zaleplon.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2001 AND VI 36 AND IP 3
Results: 17
1
2
Drug use issues and actions. Extending acyclovir's dosing interval in bone marrow transplant maintains efficacy, reduces costs.
- Published in:
- 2001
- Publication type:
- Journal Article
3
Drug use issues and actions. Another use of ADR data: to target development of new programs & services.
- Published in:
- 2001
- Publication type:
- Journal Article
4
ASHP pearls: CQI process provides a template for designing clinical practice guidelines.
- Published in:
- 2001
- Publication type:
- Journal Article
5
ASHP pearls: a strategy to emulate: how one health system achieved nearly $1 million in drug cost reductions.
- Published in:
- 2001
- Publication type:
- Journal Article
6
Variance in treatment compliance and costs by antidepressant class: analysis in an HMO setting.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
7
Anakinra: an interleukin-1 receptor antagonist for treatment of rheumatoid arthritis.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
8
Vaccines for select infectious diseases.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 240
- Publication type:
- Article
9
Final privacy rule will impact almost every aspect of pharmacy operations.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 238
- By:
- Publication type:
- Article
10
More data on potential for drug interactions with zolpidem and zaleplon.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 236
- Publication type:
- Article
11
Drug Use Issues and Actions.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 234
- Publication type:
- Article
12
ASHP Pearls.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 223
- Publication type:
- Article
13
Could federal research regulations apply to MUEs, outcomes assessments, QA/QI activities?
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 213
- By:
- Publication type:
- Article
14
Variance in treatment compliance and costs by antidepressant class: Analysis in an HMO setting.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 204
- By:
- Publication type:
- Article
15
Anakinra: An interleuken-1 receptor antagonist for treatment of rheumatoid arthritis.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 191
- By:
- Publication type:
- Article
16
News Capsules.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 187
- Publication type:
- Article
17
FDA Drug Approvals.
- Published in:
- Formulary, 2001, v. 36, n. 3, p. 177
- Publication type:
- Article